The North America hospital mobile x-ray market is expected to grow from US$ 708. 1 million in 2019 to US$ 1,559. 6 million by 2027; it is estimated to grow at a CAGR of 10. 4% 2019-2027. In this new era of preventive care, most of the market players and medical practitioners are investing in mobile X-ray systems.
New York, Aug. 16, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "North America Hospital Mobile X-ray Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Technology ; Configuration ; Ward" – https://www.reportlinker.com/p06103265/?utm_source=GNW
The adoption of mobile X-ray system offers benefits to both medical practitioners and patients. One of the major benefits of mobile X-ray systems is its capability to avoid extra movements and transports of patients with severe health conditions. Many mobile X-ray systems are equipped with a stand on wheels, while some are motorized, enabling technologists to transport the X-ray system easily and quickly. For instance, a new digital mobile X-ray system launched by Canon Medical in August 2020 is equipped with enhanced technologies that can streamline bedside exams to improve the workflow and productivity of medical imaging. Additionally, the system offers security features such as anti-collision technologies and pressure sensitive steering for secure imaging.
In addition, mobile digital X-ray systems enable quick image capturing and processing with the help of intuitive software.Also, the results are accessed in real-time and can be directly shared with patient’s physician, which helps them proceed with further treatment processes.
In May 2020, Aspen Imaging Healthcare received FDA approval for its AiRTouch, a lightweight mobile X-ray.This newly approved device enables quick image capturing and processing.
Such benefits of hospital mobile X-ray systems drives the growth of the hospital mobile X-ray market.
The North America hospital mobile x-ray market is segmented on the basis of technology, configuration, and ward.Based on technology, the market is bifurcated into computed radiography and direct radiography.
In 2019, the computed radiography segment accounted for a larger share of the market.The market growth for this segment is attributed to the increasing adoption rate of these advanced devices for medical examinations and rising number of advanced diagnostic imaging facilities.
However, the direct radiography segment is anticipated to register a higher CAGR by 2027.
North America is recording an exponentially rising deaths due to COVID-19.Disruption in supply chain and decline in demand hindered the businesses in the region.
The outbreak is leveraging the technology adoption and its usability to streamline the process of COVID-19 diagnosis.For instance, in March 2020, American College of Radiology gave approval for the utilization of artificial intelligence (AI) with the help of CT scanners and X-rays to detect COVID-19 patient.
Additionally, government and healthcare authorities are focusing on the utilization of modern technologies.For instance, in April 2020, FDA issued new guidelines to expand the availability and capability of medical diagnostic systems such as X-ray, ultrasound, and magnetic resonance imaging systems for the detection of COVID-19.
These factors are offering lucrative opportunities for the North America hospital mobile x-ray market during the pandemic.
The overall North America hospital mobile x-ray market size has been derived using both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.
The process also serves the purpose of obtaining an overview and forecast for the North America hospital mobile x-ray market with respect to all the segments pertaining to the region.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic.
The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the North America hospital mobile x-ray market. Agfa-Gevaert Group, SEDECAL, IDETEC MEDICAL IMAGING, Koninklijke Philips N.V., DMS Imaging, Carestream Health Inc., INTERMEDICAL S.r.l. IMD Group, DELFT IMAGING, and OR Technology are among the players operating in the market.
Read the full report: https://www.reportlinker.com/p06103265/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
Last week, Carnival (NYSE: CCL) (NYSE: CUK) announced that it had a COVID-19 outbreak involving 27 people on one of its operating cruise ships. The drop continued today, even after the company put out updated safety protocols over the weekend. Carnival shares dropped another 4% early Monday, but the stock pared its decline and remained down slightly more than 2% as of 10:25 a.m. EDT.
Shares of Enlivex Therapeutics Ltd. soared 21.4% toward a five-month high, enough to pace all premarket gainers early Monday, after the Israel-based immunotherapy company said it received the OK to start a Phase 2b clinical trial for its treatment of severe and critical COVID-19 patients with acute respiratory distressed syndrome (ARDS). The Israel Ministry of Health authorized the trial after reviewing Phase 2 trial data. The Phase 2b trial is expected to recruit up to 152 patients in Israel an
(Bloomberg) — New York City’s museums and cultural institutions will require visitors and staff to be vaccinated, Mayor Bill de Blasio said. New York state mandated that all health-care workers must have at least their first dose of a Covid vaccine by Sept. 27.Hopes that the world will ever to reach herd immunity against Covid-19 are fading. Pfizer Inc. and BioNTech SE submitted early-stage data to U.S. regulators showing that a third dose of their Covid-19 vaccine led to higher levels of prote
Analysts at Jefferies say that a substantial commercial opportunity remains for the company that develops a good Covid-19 therapeutic.
The COVID-19 vaccines available in the U.S. have all been found to be highly effective. But as the Delta variant has quickly spread to become the dominant strain, breakthrough infections in fully vaccinated people have become more of a concern for some. But during a recent interview, Anthony Fauci, MD, chief White House COVID adviser, took time to warn people who got the Pfizer vaccine to not do one thing in the wake of a new study.RELATED: If You Did This Before Your Pfizer Vaccine, You May Be
The new federal guidelines focus on potential conflicts of interest and what obligations your adviser owes you to help you make wise financial choices
Blue Origin, the space company helmed by billionaire Jeff Bezos, is taking NASA to court. The company filed a complaint with a federal claims court on Monday over the agency’s decision to award a lunar lander contract solely to rival company SpaceX. The complaint, which Blue Origin successfully petitioned to have sealed, says NASA's evaluation of proposals for the the Human Landing System was "unlawful and improper."
Everyone knows that you should save for retirement, but many don’t do it at all. Unfortunately, retirement without savings isn’t pretty.
Atai Life Sciences Launches New Salvia Divinorum Subsidiary Atai Life Sciences (NASDAQ: ATAI) announced the launch of a new subsidiary that will research Salvinorin A, the active compound in salvia divinorum, a hallucinogenic herb native to Central America. Revixia Life Sciences is the newest addition to Atai’s portfolio. The companies expect to begin clinical trials on Salvinorin A in the second half of 2022. Salvinorin A has been described as a dissociative psychedelic that differs from “class
At President Joe Biden’s urging, the auto industry pledged to boost production of electric vehicles to the point that they account for about half of total U.S. sales by 2030, a plan that raises hopes that EVs can shift from niche to normal. The research provider expects that share to increase to 11% in 2025; by 2030, it expects that slightly over a third of vehicles sold in the U.S. will be electric. Here are each major car maker’s stated plans for EVs, including, when available, investment amounts and the range of models they hope to bring to market.
Citibank is set to be paid £59m of that total from lending money on the Parker side of the deal.
FRANKFURT (Reuters) -Bayer, trying to contain billions of dollars in legal costs, filed a petition with the U.S. Supreme Court to reverse an appeals court verdict that upheld damages to a customer blaming his cancer on the German group's glyphosate-based weedkillers. Bayer last week lost a third appeal against verdicts that sided with users of glyphosate-based Roundup, awarding them tens of millions of dollars each, leaving the drugs and pesticides group to pin hopes for relief on the United States' top court. Bayer on Monday asked the Supreme Court to review one such verdict by the federal 9th U.S. Circuit Court of Appeals that found in favour of California resident and Roundup user Edwin Hardeman, it said in a statement.
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Ste. Michelle Wine Estates, Nu Mark, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10.2% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020.
Yahoo Finance’s Myles Udland, Julie Hyman and Brian Sozzi speak with ZipRecruiter CEO Ian Siegel about the company’s Q2 earnings report, outlook for the labor market, the future of remote work, and much more.
The technology sector is filled with high-growth companies vying for market share. Rather than pay dividends, many of these businesses prefer to reinvest excess cash in their operations, a strategy that makes sense given the quickly changing nature of technology. With that in mind, we asked three Motley Fool contributors to write about tech stocks with strong dividends.
Huawei has been accused of pushing a US company into installing a data backdoor for a Pakistani project, but the truth isn't clear.
Esther Tan Ling Ying, who had returned from London, went to a food court and a clinic despite being on SHN.
(Bloomberg) — Oil fell for a third consecutive day as Chinese economic data disappointed and the spread of the delta coronavirus variant hurt prospects for global demand.West Texas Intermediate futures slumped as much as 3.8% before as fresh outbreaks in Asia have started weighing on China’s economy, with retail sales growth and industrial output slowing. U.S. stock markets were also weaker, with energy and travel-related companies slumping on worries that further restrictions could threaten na
The 16-year-old teenager who suffered a heart attack six days after receiving his first dose of the Pfizer-BioNTech/Comirnaty COVID-19 vaccine will be eligible for a one-time financial assistance of $225,000.
Warning of tough days ahead with surging COVID-19 infections, the director of the National Institutes of Health said Sunday the U.S. could decide in the next couple weeks whether to offer coronavirus booster shots to Americans this fall.